As questions grow over its NHS data deal, Palantir’s recent contract losses in the UK highlight concerns about procurement rules, escalating prices and overstated benefits, writes Martha Dark.
As Palantir's recent UK contract losses highlight concerns over procurement, pricing and the lack of evidence behind its claims, writes Martha Dark.www.techpolicy.press
